Player FM 앱으로 오프라인으로 전환하세요!
들어볼 가치가 있는 팟캐스트
스폰서 후원
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
Manage episode 393184939 series 2829082
Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
205 에피소드
Manage episode 393184939 series 2829082
Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
205 에피소드
모든 에피소드
×1 Yannick Romero on the changing landscape of national cancer control plans 24:40
1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15
1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07
1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21
1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45
1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22
1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41
1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56
1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08
1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05
1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22
1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
1 Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 34:43
1 Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 16:06
1 Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma 13:53
1 Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery 43:49
1 Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma 17:10
1 Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA 12:31
1 Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma 33:50
1 Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children 28:40
1 Sameer Bakhshi on sex disparities in childhood cancer in India 23:02
1 Shankar Siva on radiotherapy for primary renal cell carcinoma 8:30
1 Mark Lawler and Richard Sullivan on the European Groundshot 23:20
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.